<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Basic and Clinical Neuroscience Journal</title>
<title_fa>مجله علوم اعصاب پایه و بالینی</title_fa>
<short_title>BCN</short_title>
<subject>Medical Sciences</subject>
<web_url>http://bcn.iums.ac.ir</web_url>
<journal_hbi_system_id>137</journal_hbi_system_id>
<journal_hbi_system_user>journal137</journal_hbi_system_user>
<journal_id_issn>2008-126X</journal_id_issn>
<journal_id_issn_online>2228-7442</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.32598/bcn</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1392</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2014</year>
	<month>2</month>
	<day>1</day>
</pubdate>
<volume>5</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Mu Opioid Receptor Gene: New Point Mutations in Opioid Addicts</title>
	<subject_fa>Behavioral Neuroscience</subject_fa>
	<subject>Behavioral Neuroscience</subject>
	<content_type_fa>Original</content_type_fa>
	<content_type>Original</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;&lt;b&gt;Introduction:&lt;/b&gt; Association between single-nucleotide polymorphisms (SNPs) in mu opioid receptor gene and drug addiction has been shown in various studies. Here, we have evaluated the existence of polymorphisms in exon 3 of this gene in Iranian population and investigated the possible association between these mutations and opioid addiction. &lt;/p&gt;

&lt;div&gt;&lt;b&gt;Methods:&lt;/b&gt; 79 opioid-dependent subjects (55 males, 24 females) and 134 non-addict or control individuals (74 males, 60 females) participated in the study. Genomic DNA was extracted from volunteers’ peripheral blood and exon 3 of the mu opioid receptor gene was amplified by polymerase chain reaction (PCR) whose products were then sequenced. &lt;/div&gt;

&lt;div&gt;&lt;b&gt;Results: &lt;/b&gt;Three different heterozygote polymorphisms were observed in 3 male individuals: 759T&gt;C and 877G&gt;A mutations were found in 2 control volunteers and 1043G&gt;C substitution was observed in an opioid-addicted subject. Association between genotype and opioid addiction for each mutation was not statistically significant. &lt;/div&gt;

&lt;div&gt;&lt;b&gt;Discussion:&lt;/b&gt; It seems that the sample size used in our study is not enough to confirm or reject any association between 759T&gt;C, 877G&gt;A and 1043G&gt;C substitutions in exon 3 of the mu opioid receptor gene and opioid addiction susceptibility in Iranian population.&lt;/div&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Addiction, OPRM1 Gene, Polymorphism.</keyword>
	<start_page>18</start_page>
	<end_page>21</end_page>
	<web_url>http://bcn.iums.ac.ir/browse.php?a_code=A-10-1-190&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Amin</first_name>
	<middle_name></middle_name>
	<last_name>Dinarvand</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>1370031947532846006415</code>
	<orcid>1370031947532846006415</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Science and Research Branch of Islamic Azad University, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Ali</first_name>
	<middle_name></middle_name>
	<last_name>Goodarzi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>1370031947532846006416</code>
	<orcid>1370031947532846006416</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Nasim</first_name>
	<middle_name></middle_name>
	<last_name>Vousooghi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>1370031947532846006417</code>
	<orcid>1370031947532846006417</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Neuroscience, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mehrdad</first_name>
	<middle_name></middle_name>
	<last_name>Hashemi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>1370031947532846006418</code>
	<orcid>1370031947532846006418</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Genetics, Islamic Azad University, Tehran Medical Branch, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Rasoul</first_name>
	<middle_name></middle_name>
	<last_name>Dinarvand</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>1370031947532846006419</code>
	<orcid>1370031947532846006419</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Fahimeh</first_name>
	<middle_name></middle_name>
	<last_name>Ostadzadeh</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>1370031947532846006420</code>
	<orcid>1370031947532846006420</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Science and Research Branch of Islamic Azad University, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Ahad</first_name>
	<middle_name></middle_name>
	<last_name>Khoshzaban</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>1370031947532846006421</code>
	<orcid>1370031947532846006421</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mohammad-Reza</first_name>
	<middle_name></middle_name>
	<last_name>Zarrindast</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>1370031947532846006422</code>
	<orcid>1370031947532846006422</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
